Who Owns Phio Pharmaceuticals Stock?
NASDAQ: PHIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 10.21%
- Held by insiders
- 8.01%
- Institutional holders
- 27
- Institutions 10.2%
- Insiders 8.0%
- Public and other 81.8%
Who owns Phio Pharmaceuticals stock?
Institutional investors own about 10.2% of Phio Pharmaceuticals's shares, spread across 27 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 8.01% of PHIO.
The largest institutional holders are Jane Street Group, LLC (1.01%), Geode Capital Management, LLC (0.99%) and Vanguard Capital Management LLC (0.81%). Together, the top 10 institutions control 5.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their PHIO positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PHIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Jane Street Group, LLC | 117.75K | 1.01% | -1.2% |
| Geode Capital Management, LLC | 114.57K | 0.99% | -22.2% |
| Vanguard Capital Management LLC | 94.26K | 0.81% | +18.0% |
| Nomura Asset Management International Inc | 50.00K | 0.43% | +100.0% |
| Cetera Investment Advisers | 47.50K | 0.41% | +5.6% |
| Citadel Advisors Llc | 47.15K | 0.41% | +100.0% |
| Vanguard Fiduciary Trust Co | 38.17K | 0.33% | 0.0% |
| Northern Trust Corporation | 27.77K | 0.24% | +16.9% |
| Two Sigma Investments, LP | 21.50K | 0.19% | -33.8% |
| Xtx Topco Ltd | 18.48K | 0.16% | -25.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PHIO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 94.26K | 0.81% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 61.36K | 0.53% |
| Delaware Group Equity Funds IV-Nomura Healthcare Fund | 50.00K | 0.43% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 14.66K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 13.29K | 0.11% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 12.00K | 0.10% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 4 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Phio Pharmaceuticals?
Jane Street Group, LLC is the largest institutional shareholder of PHIO, owning 1.01% of shares outstanding (117.75K shares) as of its latest 13F filing.
What percentage of Phio Pharmaceuticals is owned by institutions?
Institutions own about 10.2% of PHIO shares and 11.1% of the public float.
How much of Phio Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 8.01% of PHIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.